Genmab A/S Earnings
NASDAQ: GMABHealth CareBiotechnology: Pharmaceutical PreparationsUSD
37.07+1.02 (+2.83%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Nov 5, 2026
Before market open
Fiscal period
Sep/2026
EPS estimate
$0.37
Genmab A/S earnings summary
Genmab A/S is scheduled to report Sep/2026 earnings on Nov 5, 2026 before the market opens, with analysts expecting EPS of $0.37.
Summary generated from market data by MetaCap's automated system. Methodology